U.S. Biotech company CohBar develops mitochondria-based therapeutics for age-related diseases

OAN Newsroom
UPDATED 12:08 PM PT – Wednesday, April 21, 2021

U.S. biotech company CohBar is developing mitochondria-based therapeutics for age-related diseases. One America’s Stephanie Myers spoke with CohBar CEO Steven Engle about the progress and clinical programs they are developing to combat these diseases.

MORE NEWS: UNICEF reports sharp increase in undocumented minors